Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 1.

Patient Characteristics

Variables N = 328
Age (yr) 50.0 ± 17.2
Sex (M/F) 164/164
Previous illness
None 177 (59.8)
Hypertension 48 (16.2)
Diabetes mellitus 23 (7.8)
Othersa 58 (19.6)
Medication history
None 249 (84.1)
Anti-platelets 12 (4.1)
Warfarin 2 (0.7)
NOAC 2 (0.7)
Steroids 2 (0.7)
Others 10 (3.4)
Diagnosis
Type I 121 (36.9)
Type II 138 (42.1)
Type III 48 (14.6)
Distal esophageal spasm 4 (1.2)
Jackhammer esophagus 4 (1.2)
EGJ outflow obstruction 6 (1.8)
Unclassified (manometry fail, etc) 7 (2.1)
Previous treatment
Naïve 242 (73.8)
Balloon dilatation 64 (19.5)
Botox injection 12 (3.7)
Heller’s myotomy 5 (1.5)
POEM 5 (1.5)
Esophageal myotomy length (cm) 8.5 (6.2-10.0)
Gastric myotomy length (cm) 3.0 (2.0-3.0)
POEM procedure time (min) 70.0 (55.0-87.0)
Length of hospital stay after POEM (days) 5.0 (4.0-6.0)
Meaningful discharge delay due to adverse events 43 (13.1)

aHeart disease (coronary artery disease, atrial fibrillation, and congestive heart failure), cerebrovascular disease (cerebrovascular accident and Parkinson’s disease), etc.

M, male; F, female; NOAC, novel oral anti-coagulant; EGJ, esophagogastric junction; POEM, peroral endoscopic myotomy.

Data are presented as mean ± SD, n, n (%), or median (interquartile range [IQR]).

J Neurogastroenterol Motil 2022;28:247~254 https://doi.org/10.5056/jnm21081
© J Neurogastroenterol Motil